IPA-based disease and function analysis suggested that after CX3CL1 was inhibited, tumor cell proliferation (P=1.62×10-11, z-score=-2.32), cell malignant transformation (P=6.47×10-13, z-score=-2.289), tumor cell interphase (P=1.57×10-12, z-score=-2.078) and differentiation of stem cells (P=4.02×10-5, z-score=-2.465) were significantly inhibited, and tumor cell apoptosis (P=2.35×10-7, z-score=2.236) was significantly increased (Figure 4A). The gene discussed is CX3CL1; the disease is neoplasm.